OverviewChartNewsTraderScreen

Morgan Stanley Put 150 PGR 20.09..../  DE000ME3YJD8  /

Stuttgart
2024-06-28  2:09:50 PM Chg.-0.016 Bid4:52:04 PM Ask4:52:04 PM Underlying Strike price Expiration date Option type
0.154EUR -9.41% 0.173
Bid Size: 15,000		 0.186
Ask Size: 15,000		 Progressive Corporat... 150.00 USD 2024-09-20 Put
GlobeNewswire 5:01 PM Tiziana Receives $3.4 Million in Non-Dilutive Funding
GlobeNewswire 4:17 PM KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid My...
GlobeNewswire 3:00 PM Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle a...
GlobeNewswire 2:00 PM Eyenovia Announces Pricing of $5M Registered Direct Offering
GlobeNewswire 1:00 PM Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire 12:57 PM Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographi...
GlobeNewswire 7:00 AM XPPen to Showcase Diverse Innovative Products at Anime Expo 2024
GlobeNewswire 1:39 AM “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire 12:30 AM Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
Newsfile Corp 06-27 APFC Coin (APFC) Is Now Available for Trading on LBank Exchange
GlobeNewswire 06-27 UFL CONCLUDES INAUGURAL SEASON WITH SIGNIFICANT GROWTH ACROSS KEY CONSUMER METRICS
GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 06-14 Progressive Reports May 2024 Results
GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...